Advanced Oncotherapy PLC (LSE:AVO) - Share price - Overview

Stock Report

Advanced Oncotherapy PLC AVO

Last Price
GBX57.69

Day Change
5.49|10.51%

As of 22/05/2018
11:06:53 BST | GBX
Minimum 15 Minutes Delay.

Last Close52.20p
Day Range53.95 - 57.69
Mkt Cap80.52Mil
52-Wk Range9.53 - 64.80
Yield %-
ISINGB00BD6SX109
Volume44,811
P/E-3.38
P/SInfinity
P/CF-0.03

Share Price

Total Returns 21/05/2018

 Chg (%)  
More ...
Advanced Oncotherapy PLC13.48 
FTSE 100 TR GBP7.00
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-5.04-7.62-13.09
Net Profit-5.70-5.85-10.37
Reported EPS-16.75-11.43-17.05
Balance Sheet
Current Assets3.1716.6812.54
Non Current Assets11.3014.0625.13
Total Assets14.4730.7437.67
Current Liabilities3.333.463.68
Total Liabilities3.333.463.68
Total Equity11.1327.2833.99
Cash Flow
Operating Cash Flow-6.56-9.85-13.38
Net Change in Cash1.327.49-7.51
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/01/2018PurchaseDr Enrico Cipro Vanni54.5040,00021,800.00
31/07/2017PurchaseDr Enrico Cipro Vanni17.75100,00017,750.00

Company Profile

Advanced Oncotherapy PLC is a medical care company which utilizes radiation-based treatment. Its technologies address serious illness in patients such as tumors.

Sector

Medical Devices

Index

FTSE AIM All-Share

Next Event 26/06/2018

Final Results
Ratios
Comp
More ...
PER (E)0.23
Div Yld (E)0.00
PEG (E)0.00
ROCE-38.47
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr Enrico Cipro Vanni
Non-Executive DirectorMr. Michael Bradfield
Executive Director, Vice President, Global Business DevelopmentMr. Sanjeev Pandya
Executive Director, Chief Executive OfficerNicolas Serandour
Non-Executive DirectorProfessor Stephen Myers OBE
Non-Executive DirectorProfessor Christopher Nutting
Non-Executive DirectorDr. Piers Nicholas Plowman
Executive Director, ChairmanDr. Michael Jeffrey Sinclair
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.